Eversept Partners’s Viatris VTRS Stock Holding History

Eversept Partners’s Portfolio VTRS Stock Details VTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-158,600	Closed	-$4.35M	–	63
2018 Q4	$4.35M	Buy	+158,600	New	+$5.14M	2.35%	12

Other funds holding VTRS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Eversept Partners's VTRS Position: Q1 2025 in Review

Eversept Partners sold out of Viatris (VTRS) in Q1 2025, closing a stake of 1,272,102 shares — an estimated $15.8M sold.

Eversept Partners first reported a position in VTRS in Q4 2018 and held it in 6 quarters. The position peaked at $20M in Q3 2024. 1,010 funds tracked by Wall St. Rank hold VTRS as of Q1 2025.

Eversept Partners reported no remaining Viatris position as of Q1 2025 after selling out during the quarter.
Eversept Partners sold 1,272,102 Viatris shares in Q1 2025, an estimated $15.8M.
Eversept Partners first reported a position in Viatris in Q4 2018 and held it in 6 quarters.
Eversept Partners's Viatris position peaked at $20M in Q3 2024.
1,010 funds tracked by Wall St. Rank held Viatris as of Q1 2025.

Based on Eversept Partners's 13F filing for Q1 2025, filed 15 May 2025.